John Russell

John Russell currently serves as the Director of Laboratory Automation at Life Edit Therapeutics, a position held since January 2022. Prior to this role, John worked as a Principal Scientist in Automation Sciences and Integration at KBI Biopharma from October 2018 to January 2022 and as a Lead Automation Consultant at LHR Automation between May 2015 and September 2018. With a focus on enabling automation in early drug discovery processes, John provides expertise in software and hardware support, particularly in plate handling, liquid handling, and compound management inventory systems. John’s earlier experience includes an Investigator role at GlaxoSmithKline from August 2004 to 2015, where responsibilities involved the purchase, maintenance, and method creation for laboratory automation suites, as well as designing processes for biological assays. John holds a Bachelor of Science degree in Science Education from North Carolina State University, earned in 2004.